baber/WOPTO huggingface dataset:
Patent EP-2347552-A2 (EP)
Inventor: BATHRICK ERWIN W
IPC: H04L45/28
Filed: 2009-11-12
Abstract: L'invention concerne un système et un procédé destinés à assurer des services de réseau tolérant aux retards (delay tolerant networking, DTN) à des applications héritées. Selon un mode de réalisation, un procédé destiné à assurer des services DTN à des applications héritées comporte les étapes consistant à intercepter un paquet adressé à une application logicielle, le paquet comprenant une charge utile, l’application logicielle étant résidente sur un premier ordinateur, à déterminer l’aptitude du paquet à un traitement DTN et à coder la charge utile en un groupe DTN. Selon un autre mode de réalisation, un système destiné à assurer des services DTN à des applications héritées comprend une interface de réseau, une mémoire et une unité de commande couplée à l’interface de réseau et à la mémoire. Dans ce mode de réalisation, l’unité de commande est configurée de façon à intercepter un paquet adressé à une application logicielle, le paquet comprenant une charge utile, l’application logicielle étant résidente sur un ordinateur, à déterminer l’aptitude du paquet à un traitement DTN et à coder la charge utile en un groupe DTN.
Patent EP-2357003-A2 (EP)
Inventor: HONG HYO JEONG
IPC: A61K33/243
Filed: 2009-11-27
Abstract: The present invention relates to an anticancer composition comprising an antitumor agent as well as a substance having inhibitory effects on the activity or expression of L1CAM; more particularly, to an anticancer composition, which comprises an anti-L1CAM antibody specific to L1CAM, serving as a substance for inhibiting the activity of L1CAM; an oligonucleotide inhibiting the generation of L1CAM, serving as a substance for inhibiting the expression of L1CAM; and a substance selected from cisplatin, gemcitabine, 5-fluorouracil and taxol, serving as an antitumor agent. The composition according to the present invention has the benefit of the combined use of a substance having inhibitory effects on the activity or an expression of L1CAM and an antitumor agent concurrently, separately or sequentially so that it demonstrates stronger and more significant pharmaceutical effects than the exclusive use of those substances on inhibiting proliferation and inducing apoptosis in cancer cells, thereby making it very useful for cancer treatment.
Patent EP-2226500-A2 (EP)
Inventor: WITTEK THOMAS
IPC: H02J3/38
Filed: 2010-03-02
Abstract: The method involves specifying a desired value that characterizes idle power of a wind park, and monitoring actual value of individual idle power (q1 to q5) and individual active power of single wind energy plant. The reactive power and the active power are computed at network connection point by a load flow calculation (3) from the values.
Patent EP-2332981-A2 (EP)
Inventor: TUERECI OEZLEM
IPC: A61K39/00
Filed: 2004-09-23
Abstract: Pharmaceutical composition (A) comprises an agent (B) that inhibits the activity or expression of a specific tumor-associated antigen (TAg) that is encoded by one of the following nucleic acids (NA): (a) any of 75 sequences (reproduced) or their fragments or derivatives; (b) a sequence that hybridizes to (a) under stringent conditions; (c) degenerate variants of (a) or (b); or (d) a complement of (a)-(c). Independent claims are also included for the following: (1) similar composition (A1) containing an agent (B1) with tumor-inhibiting action selective for cells showing (abnormal) expression of TAg; (2) similar composition (A2) containing an agent (B2) that selectively increases the amount of complex formed between an HLA molecule and TAg (or part of it); (3) pharmaceutical composition (A3) comprising TAg, NA, antibodies directed against TAg (or their fragments), antisense nucleic acid that hybridizes to NA, host cells that express TAg (or fragment), or isolated complexes of TAg with an HLA molecule; (4) method for diagnosing a disease associated with (abnormal) expression of TAg; (5) method for determining regression, progression and onset of a disease associated with (abnormal) expression of TAg; (6) several methods for treating diseases associated with (abnormal) expression of TAg; (7) method for treating, diagnosing and monitoring diseases associated with (abnormal) expression of TAg by administering an antibody, optionally linked to a therapeutic or diagnostic agent, that binds to TAg; (8) NA, or any nucleic acid that encodes the same proteins, as new compounds; (9) recombinant DNA or RNA containing the nucleic acid of (8); (10) host cells that contain the nucleic acids of (8) or (9); (11) proteins and polypeptides (P) encoded by the nucleic acids of (8), also their immunogenic fragments that bind to a human HLA receptor or human antibody; (12) agent (X) that binds specifically to (P), or part of it; (13) antibody (Ab) that binds selectively to a complex of (P), or its fragment, and an MHC molecule; (14) conjugate between (X) or Ab and a therapeutic or diagnostic agent; (15) kit for detecting (abnormal) expression of TAg; (16) recombinant DNA containing a promoter region derived from any of the 75 specified sequences; (17) pharmaceutical composition containing an agent that inhibits expression or activity of a tumor-associated antigen (TAg1) having any of 75 amino acid sequences reproduced; and (18) antibody (Ab1) that binds to an extracellular domain of TAg1. ACTIVITY : Cytostatic. No details of tests for cytostatic activity are given. MECHANISM OF ACTION : Inhibiting expression or activity of specific antigens; Antisense therapy; RNA Interference.
Patent EP-2363821-A2 (EP)
Inventor: RAAB DAVID
IPC: C12N15/11
Filed: 2003-12-23
Abstract: Computer optimization of a nucleotide sequence for a protein comprises generating a test sequence; establishing positions corresponding to codons to be optimized; generating further test sequences by replacing one or more of these codons with another codon for the same amino acid; evaluating the test sequences with a quality function to determine the optimum sequence; establishing codons of the optimum sequence as success codons; and iterating the above steps without changing the success codons. Computer optimization of a nucleotide sequence for expression of a protein comprising N amino acids comprises generating a test sequence of n codons corresponding to n contiguous amino acids of the protein sequence, where n is =N; establishing m positions corresponding to codons to be optimized, where m is = n and less than N; generating one or more further test sequences by replacing one or more of the m codons with another codon encoding the same amino acid; evaluating the test sequences with a quality function to determine the optimum sequence; establishing p codons of the optimum sequence as success codons, where p is =m; and iterating the above steps without changing the success codons. Independent claims are also included for: (1) computer apparatus for optimization of a nucleotide sequence for expression of a protein, comprising means for performing the above steps; (2) computer program for performing the above method; (3) data carrier on which the above program is stored in computer-readable form; (4) nucleic acid (I) comprising a protein-encoding nucleotide sequence produced by synthesizing the sequence optimized as above; (5) nucleic acid (II) comprising one of four defined nucleotide sequences; (6) vector containing (I) or (II); (7) cells containing the vector or (I) or (II); (8) organism comprising at least one cell as above.
Patent EP-2208958-A2 (EP)
Inventor: HELLSTROM JOHANNES
IPC: F41A19/66
Filed: 2010-01-15
Abstract: An electronic apparatus for controlling a firing rate of an automatic firing weapon having an actuator (SDRV) adapted to operate a trigger mechanism of said weapon, said weapon exhibiting a natural free-running firing rate when triggered. The apparatus comprises an output driver means (MMV1) adapted to provide a drive signal (Q1) for said actuator (SDRV), 
a first single pulse generator (AMV1) means having a single pulse output (5) coupled to an input of the driver means (MMV1) and adapted to generate a single pulse of a duration shorter than a time period of said natural free-running firing rate in response to a single pulse generator means input, and a pulse train generator means (MMV2) having a single pulse output (Q3) coupled to an input of said first single pulse generator means and adapted to provide to the first single pulse generator means (AMV1) a train of pulses spaced in time a spacing period exceeding said time period of said natural free-running firing rate in response to a pulse train generator means (MMV2) input.
Patent EP-2272751-A2 (EP)
Inventor: JIN CHANG BAE
IPC: B63H25/38
Filed: 2010-02-22
Abstract: Disclosed herein is a ship rudder (4) disposed behind a propeller (2) at a stern of a ship (1) to control a movement direction of the ship. The rudder includes a middle blade (4a) located around an axis of the propeller and upper and lower blades (4b, 4c) located at upper and lower sides of the middle blade. The middle blade has a leading edge part having a bilaterally symmetrical shape with respect to a plane passing through the axis of the propeller and a perpendicular centerline of the rudder. The upper blade (4b) has a leading edge part twisted with respect to the plane passing through the axis of the propeller and the perpendicular centerline of the rudder to be biased in a reverse rotational direction of the propeller. The lower blade (4c) has a leading edge part twisted with respect to the plane passing through the axis of the propeller and the perpendicular centerline of the rudder to be biased in a forward rotational direction of the propeller. The leading edge part of the middle blade does not form a step, with respect to the leading edge parts of the upper and lower blades, at sides of the rudder in twisted directions of the upper and lower blades, but forms steps, where the leading edge part of the middle blade meets the leading edge parts of the upper and lower blades, at sides of the rudder in directions opposite to the twisted directions of the upper and lower blades, respectively.
Patent EP-2236947-A2 (EP)
Inventor: PICKERSGILL LOUIS
IPC: F24H8/00
Filed: 2010-03-18
Abstract: A water heating system that includes a burner unit (102) with an exhaust gas outlet (122), a primary heat exchanger (104) with primary passageways for carrying water to be heated by the burner unit (102) and an auxiliary heat exchanger (110, 108) having first passageways connected to the exhaust gas outlet (122). The auxiliary heat exchanger (108, 110) includes a secondary heat exchange unit (108) with second passageways for water and a tertiary heat exchange unit (110) with third passageways for liquid or water or air. The first passageways of the auxiliary heat exchanger (108, 110) are in heat transfer contact with the second passageways and with the third passageways.
Patent EP-2239408-A2 (EP)
Inventor: BARNES ANTONY
IPC: E06B9/50
Filed: 2010-04-06
Abstract: A shim for reducing play between a roller blind tube and a roller blind end plug, the shim including a rib receiving portion sized and configured to receive a rib from a roller blind tube, wherein the shim is capable of being located between adjacent splines of a roller blind end plug.
Patent EP-2248992-A2 (EP)
Inventor: GRAHAM BENJAMIN ERIC
IPC: F16K5/00
Filed: 2010-04-22
Abstract: For pulsed injection of liquids into the ground, the tool has a rotating cylinder, having through-slots. The tool has an insert, which is pressed against the rotating cylinder. As the cylinder rotates, the slots in the rotor cover/uncover the slots in the insert, creating the required pulses. By suitably shaping the slots, the pulses can have a fast rise-time from closed to open. The insert is shaped to minimize flow interference.
Patent EP-2256414-A2 (EP)
Inventor: CADEAU CHRISTOPHE
IPC: F24C3/12
Filed: 2010-04-30
Abstract: The arrangement has a gas valve (3) with a movable adjusting element (6). The gas valve is arranged below a hob plate (1), and an actuator (2) is manually moved by an operating person. The actuator is arranged above the hob plate, and exhibits a permanent magnet (11) such that force required for moving the adjusting element of the gas valve is transferred by magnetic force from the actuator to the adjusting element. The hob plate includes a closed surface within area between the gas valve and the actuator.
Patent EP-2290784-A2 (EP)
Inventor: RUA FRANCESCO
IPC: G05F1/67
Filed: 2010-06-17
Abstract: An outstandingly effective method of maximum power point tracking (MPPT) in operating a photovoltaic power plant that includes at least a DC-DC converter of the output voltage ( V PV   ) of a single panel or of a plurality of series-parallel interconnected panels, having a power switch driven by a PWM control signal ( V PWM   ) of variable duty-cycle  (D)  generated by a PWM control circuit, in discontinuous conduction mode (DCM) or continuous conduction mode (CCM) depending on the current load of the converter, is implemented by simple low cost analog circuits. The method does not require the use of any analog to digital conversion, digital processing or storage resources and requires only a single voltage sensor, in other words, no dissipative sensing resistance needs to be introduced.
Patent EP-2273810-A2 (EP)
Title: Method to identify a mobile station
Inventor: HANS MARTIN
IPC: H04W12/06
Filed: 1999-11-29
Abstract: The method involves defining the geographic area, the service(s) and the characteristic(s); determining the mobile stations (10,15,20,25) subscribing to the service within the geographic area via a communications network (35); checking for each detected station whether it has a defined characteristic(s); and only signalling the station if it has at least one defined characteristic.
Patent EP-2359863-A2 (EP)
Inventor: CLARKE MICHAEL F
IPC: C12N5/095
Filed: 2001-08-02
Abstract: A small percentage of cells within an established solid tumor have the properties of stem cells. These solid tumor stem cells give rise both to more tumor stem cells and to the majority of cells in the tumor that have lost the capacity for extensive proliferation and the ability to give rise to new tumors. Thus, solid tumor heterogeneity reflects the presence of tumor cell progeny arising from a solid tumor stem cell. We have developed a xenograft model in which we have been able to establish tumors from primary tumors via injection of tumors in the mammary gland of severely immunodeficient mice. These xenograft assay have allowed us to do biological and molecular assays to characterize clonogenic solid tumor stem cells. We have also developed evidence that strongly implicates the Notch pathway, especially Notch 4, as playing a central pathway in carcinogenesis.
Patent EP-2324844-A2 (EP)
Inventor: SCHNEIDER PASCAL
IPC: A61K/
Filed: 2000-10-05
Abstract: A receptor in the TNF family is provided: APRIL-R. Chimeric molecules and antibodies to APRIL-R and methods of use thereof are also provided.
Patent EP-2293187-A2 (EP)
Title: Image cropping system and method
Inventor: WALKER KENNETH A JR
IPC: H04N1/387
Filed: 2004-09-10
Abstract: Electronic document design systems and methods allowing a user engaged in customizing an electronic product to re-crop product images in a manner that is compatible with the product layout. Upon selection of an image area in the product design, the user can choose to re-crop the image currently displayed in the image area or to select and crop a different image to be used in the selected image area. A cropping indicator that can be resized and repositioned is provided to the user. The cropping indicator is automatically sized to have and retain the same height to width ratio as the selected image area. Upon completion of any resizing or repositioning operation, the selected image area of the electronic product is updated to reflect the cropping changes made by the user.
Patent EP-2464175-A2 (EP)
Inventor: DE FRANCISCO MARTIN RUBEN
IPC: H04W52/02
Filed: 2010-12-15
Abstract: The present invention is related to a method for detecting a transmitted wake-up signal in a wireless communication system comprising a plurality of communication nodes. The method comprises the steps of : 
- receiving at a communication node of said plurality a transmitted wake-up signal, said wake-up signal being split over a plurality of frequency channels and a plurality of time slots, 
- determining per frequency channel an indication of the signal quality on that frequency channel, 
- deciding per frequency channel on removing the signal portion corresponding to that frequency channel, based on the indication of the signal quality, thereby obtaining a reduced received wake-up signal, 
- correlating the reduced received wake-up signal with a version of a local copy of the transmitted wake-up signal, 
- detecting the transmitted wake-up signal from the result of the correlation step.
Patent EP-2253281-A2 (EP)
Inventor: METZGER PETER UNIV DOZ DR MED
IPC: A61B17/29
Filed: 2010-05-12
Abstract: Surgical jaw type grab has actuating element (4) shiftable against the force of spring (5) to pivot head tube (6) carrying the jaws (3) on one end of rear shaft tube; jaws pivoted between open and closed positions by actuating rod assembly formed of rigid rear rod extending coaxially in rear tube adjacent the rod, and rigid front rod extending coaxially through the head tube; and flexible flat bar fixed between front and rear ends of rear and front rods. The rear end of rear rod is connected to actuating lever (2) so that pivoting the lever control the opening and closing of jaws.
Patent EP-2340959-A2 (EP)
Inventor: MEHLER ALEXANDER
IPC: B60L11/18
Filed: 2010-11-25
Abstract: The device has a control device (6) for controlling a control switch (5) and evaluating a current measuring device (7). The control device opens the control switch in branch lines (2) depending on measurement of the current measuring device in the respective branch lines and a residual-current circuit-breaker (4). The control device closes the control switch depending on the residual-current circuit-breaker and stored measured values of the current measuring device immediately before opening the control switch together with the residual-current circuit-breaker.
Patent EP-2419478-A2 (EP)
Inventor: XU XINSHE
IPC: G01N33/58
Filed: 2010-04-16
Abstract: Compounds and methods are disclosed that are useful for noninvasive imaging in the near-infrared spectral range. The cyanine compounds of Formula (I) are presented: (I). wherein Q is a portion of a polymethine bridge selected from the group consisting of: (a) and (b). Also included are bioconjugates of the compounds of Formula (I), methods of labeling biomolecules with the compounds, and methods of imaging.
Patent EP-2424888-A2 (EP)
Title: Synthèse de peptides insulinotropiques à l'aide d'une combinaison de techniques en phase solide et soluble
Inventor: CHEN LIN
IPC: C07K14/605
Filed: 2010-04-28
Abstract: La présente invention concerne la préparation de peptides insulinotropiques comprenant la séquence d'acides aminés de (SEQ ID NO. 9) Z-HX 8 EGTFTSDVSSYLEGQAAKEFIAWLVKX 35 R-NH 2  dans laquelle Z désigne H-, et X 8  et X 35  désignent chacun indépendamment des résidus d'acides aminés achiraux, éventuellement stériquement encombrés, à l'aide d'une technique en phase solide et soluble ("hybride"). Généralement, la technique consiste à synthétiser trois fragments intermédiaires peptidiques différents à l'aide d'une chimie en phase solide. La chimie en phase solide est ensuite utilisée pour coupler le deuxième fragment et le premier fragment. Dans une variante, un deuxième fragment différent est couplé à un premier fragment dans la phase solide. Ensuite, la chimie en phase soluble est utilisée pour ajouter le troisième fragment, le troisième fragment étant ainsi couplé aux premier et deuxième fragments dans la phase soluble.
Patent EP-2494572-A2 (EP)
Title: Améliorations à et associés à des thermostats
Inventor: HUNT ANDREW
IPC: H01H37/48
Filed: 2010-10-06
Abstract: L'invention porte sur un ensemble de thermostat (1) pour commander la température d'un fluide (par exemple, de l'eau) dans un réservoir, et actionné par une dilatation différentielle entre un premier élément allongé (par exemple, un tube 7) et un deuxième élément allongé (par exemple, une tige 8) monté et fixé à une extrémité du premier élément allongé (par exemple, à l'intérieur du tube). Des premier et deuxième mécanismes de commutateur (4, 5) sont, de préférence, montés à l'autre extrémité du premier élément allongé. Le commutateur est de préférence ouvert à une température de consigne respective par le mouvement de l'extrémité libre du deuxième élément allongé (par exemple, la tige) par rapport à l'extrémité du premier élément allongé.
Patent EP-2509917-A2 (EP)
Title: Kohlenstoffpartikelgranulat, dispersion aus kohlenstoffpartikelgranulat sowie verfahren zu deren herstellung
Inventor: HELBIG JENS
IPC: C08K7/06
Filed: 2010-12-07
Abstract: Die vorliegende Erfindung umfasst ein Kohlenstoffpartikelgranulat, insbesondere ein Kohlenstoffnanopartikelgranulat und/oder ein Kohlenstoffmikropartikelgranulat, wobei das Kohlenstoffpartikelgranulat eine Anzahl von Granulatpartikelnaufweist. Das Kohlenstoffpartikelgranulat ist dabei gekennzeichnetdadurch, dass ein Granulatpartikel jeweils aus einem Primärpartikel auf Kohlenstoffbasis und wenigstens aus einem Additiv gebildet sind. Des Weiteren umfasst die vorliegende Erfindung ein Verfahren zur Herstellung dieses Kohlenstoffpartikelgranulat, sowie eine Dispersion, die dieses Kohlenstoffpartikelgranulat enthält und in einer Flüssigkeit aufgelöst ist und ein Verfahren zur Herstellung dieser Dispersion.
Patent EP-2459020-A2 (EP)
Title: Agencement de support de seins
Inventor: TYRER JOHN
IPC: A41C3/00
Filed: 2010-07-29
Abstract: Dans le domaine des agencements de support de seins, il existe un besoin pour un agencement de support de seins amélioré qui s'adapte lorsqu'une personne qui le porte se déplace, de façon à assurer un support optimal et un confort optimal dans une plage de mouvements d'une personne. A cet effet, l'invention porte sur un agencement de support de seins (10), qui comprend un premier bonnet de sein (12) qui est relié à une première partie d'aile (14), et un deuxième bonnet de sein (16) qui est relié à une deuxième partie d'aile (18). Les premier et deuxième bonnets de seins (12, 16) et des parties d'aile (14, 18) sont interconnectés par un élément de liaison (20). L'élément de liaison (20) passe du premier bonnet de sein (12) au deuxième bonnet de sein (16) par l'intermédiaire de la deuxième partie d'aile (18), puis de la première partie d'aile (14); il est mobile par rapport à chacune des première et deuxième parties d'aile (14, 18); et il est constitué par ou il inclut un élément élastique (22) pour tirer le premier bonnet de sein (12) vers la deuxième partie d'aile (18), le deuxième bonnet de sein (16) vers la première partie d'aile (14), et les première et deuxième parties d'aile (14, 18) l'une vers l'autre.
Patent EP-2460809-A2 (EP)
Inventor: LEE YONG-HO
IPC: C08F10/00
Filed: 2010-07-29
Abstract: The present invention relates to a novel metallocene compound, a catalyst composition comprising the same, and to olefinic polymers produced using the same. The metallocene compound according to the present invention and the catalyst composition comprising the same can be used when producing olefinic polymers, have outstanding copolymerisation properties, and can produce olefinic polymers of high molecular weight. In particular, when the metallocene compound according to the present invention is employed, highly heat resistant block copolymers can be produced, and olefinic polymers can be produced which have a high melting point (Tm) even if the comonomer content is increased when producing the olefinic polymer.